Nico Forraz

Dr. Nico Forraz

CTIBIOTECH, Lyon, Auvergne-Rhône-Alpes, France
orcid

Biography

Dr Forraz is Chief Executive Officer of CTIBiotech, in charge of business development, industrial operations and relations with investors and financial institutions. He has extensive expertise in stem cells, regenerative medicine and 3D tissue and with Professor Colin McGuckin was part of the team who created the world’s first artificial hepatic-like liver tissue and neural cells from human umbilical cord blood. With an interest in cross-developing clinical research for business-generating technologies, Dr Forraz has extensive experience in negotiation, business creation and operations. Dr Forraz has spear-headed the 43 Million Euro consortium generation of the IMODI Cancer project, the largest cancer research project in France, and was the winner of several international business plan competitions. Dr Forraz served between 2019 and 2022 as the President of Cosmet’in Lyon Skin Science, a not-for-profit professional organization linking researchers, interprofessional organizations and industry to share the latest scientific knowledge in dermocosmetology and promote excellence and expertise in skin care and cosmetology.

Affiliations

CTIBIOTECH

Lyon, Auvergne-Rhône-Alpes, France

Honors and Awards

honor

Creative Pioneer Programme award

NESTA: British National Endowment for Science, Technology and the Arts

Award for commercial translation of academic findings in tissue engineering in a business plan concept to incept a start up in biotechnology

honor

North East Universities Science and Technology Blueprint Business Plan Award

One North East & Newcastle University

honor

“T. Kamalagharan Research Prize”

St George’s Hospital Medical School University of London

Best Research Project in hematooncology researcg

honor

Henry Maso Award 2022

International Federation of Societies of Cosmetic Chemists

Awarded to our researcher for CTIBIOTECH (Lyon, France) was awarded the “Henry Maso Award” for the publication titled “The world’s first 3D bioprinted immune skin model suitable for screening drugs and ingredients for normal and inflamed skin” at the gala dinner and award ceremony of the IFSCC 2022 congress in Battersea Park before international academic and industrial experts of cosmetics science.

Experience

Institute, Department or Faculty Head

Cell Therapy Research Institute

01 Aug 2010 - present

President, CEO or Director

CTIBIOTECH

01 Oct 2008 - present

Senior Scientist or Principal Investigator

Newcastle University & NorthEast England Stem Cell Institute (NESCI

01 Dec 2005 - 01 Oct 2008

Senior Scientist or Principal Investigator

Kingston University

01 Mar 2004 - 01 Dec 2005

Post Doctoral Researcher

St George's Hospital Medical School, London, United Kingdom

01 Feb 2003 - 01 Feb 2004